Global Aesthetic Medicine Market Report 2022

ReportLinker

The major players in the aesthetic medicine market are Allergan Plc, Alma Lasers, Cutera, Cynosure, Galderma, Galderma Laboratories, Johnson & Johnson, Lumenis, Merz Pharmaceuticals, Solta Medical, AbbVie, Syneron Candela, El.

New York, July 29. 2022 (GLOBE NEWSWIRE) — Reportlinker.com Announces Release of “Aesthetic Medicine Global Market Report 2022″ – https://www.reportlinker.com/p06310824/?utm_source=GNW
Fr. SpA, Dentsply Sirona Inc, Evolus, Fotona doo, Medytox Inc, GC Aesthetics, Sientra and Skin Tech Pharma Group.

The global aesthetic medicine market is expected to grow from $51.60 billion in 2021 to $56.73 billion in 2022 at a compound annual growth rate (CAGR) of 9.94%. The aesthetic medicine market is expected to reach $82.87 billion in 2026 at a compound annual growth rate (CAGR) of 9.94%.

The aesthetic medicine market includes sales of aesthetic medicine by entities (organizations, individual traders and partnerships) that refer to non-invasive and minimally invasive devices and instruments, designed to perform procedures aimed at improving the physical appearance and patient satisfaction. Medico-aesthetic treatments performed through these aesthetic medicine products include non-invasive lipolysis, restoration and hair removal, cellulite reduction, wrinkle reduction, skin renewal and resurfacing, etc.

The main products of aesthetic medicine include facial aesthetics products, body contouring devices, cosmetic implants, hair removal devices, skin aesthetics devices, tattoo removal devices, lifting products thread, doctor-dispensed cosmeceuticals and skin lighteners, doctor-dispensed eyelash products, and nail products. laser treatment devices. Facial aesthetics refers to products used in facial aesthetic treatments and procedures.

Facial aesthetics is a range of non-surgical treatments performed on the face, which includes botox, fillers and anti-wrinkle injections. Types of procedures in aesthetic medicine include invasive procedures and non-invasive procedures.

They are used in clinics, hospitals, medical spas, beauty centers and home care units.

North America was the largest region in the aesthetic medicine market in 2021. Asia-Pacific is expected to be the fastest growing region during the forecast period.

Regions covered in the Aesthetic Medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Aesthetic Medicine Market research report is one of a series of new reports that provide statistics on the Aesthetic Medicine market, including the global Aesthetic Medicine industry market size, shares regions, competitors holding Aesthetic Medicine market share, detailed Aesthetic Medicine market segments, market trends and opportunities. , and any other data you may need to thrive in the aesthetic medicine industry. This Aesthetic Medicine Market research report provides a comprehensive perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Growing obese populations across the globe are expected to propel the growth of the aesthetic medicine market. Rising consumption of unhealthy foods, lack of physical activity, and parental and postnatal influences are contributing to the rapid growth of the obese population across the world.

Obese people seek aesthetic medicine for fat reduction, meso/lifting and other benefits through various invasive and non-invasive aesthetic medicine procedures. For example, in 2019, according to a European Health Survey of the Overweight or Obese Population in Europe conducted by Eurostat, the statistical office of the European Union, reported that 52.7% of Europe’s adult population was overweight. Hence, the growing number of obese populations across the globe is expected to drive the growth of the aesthetic medicine market.

The development of new products for a wide range of skin types is a key trend in the aesthetic medicine market. Aesthetic medicine companies focus on launching new products and solutions to meet the needs of various skin types and expand their customer base.

These products can be used in treatment and patient care for a wide range of skin types resulting in a wider range of applications. For example, in September 2020, Allergan Aesthetics, a US pharmaceutical company, and Skinbetter Science, a US-based skincare company launched the DREAM initiative (DREAM: Driving Racial Equity in Aesthetic Medicine).

This will help in the development of new products for all kinds of racial and ethnic groups so that aesthetic providers can meet the needs of all patients. Additionally, in March 2020, Galderma, a Swiss pharmaceutical company, announced that it is making significant investments to expand its aesthetic portfolio, including digital enhancements for ASPIRE Galderma Rewards.

In May 2020, AbbVie, an American biopharmaceutical company, acquired Allergan for $63 billion. This acquisition is expected to diversify AbbVie’s portfolio and create profitability in R&D commercialization activities.

Allergan is an American developer and manufacturer of aesthetic drugs and other products.

The countries covered in the Aesthetic Medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the United Kingdom and the United States.
Read the full report: https://www.reportlinker.com/p06310824/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001